Pharmacotherapy Update Newsletter
from the Cleveland Clinic Department of Pharmacy
Current Issues
| Archive 2021 - 2022
| Archive 2019 - 2020
| Archive 2017 - 2018
Archive 2015 - 2016
| Archive 2013 - 2014
| Complete Archive
Pharmacotherapy Update Newsletter Archive
November/December 2012
Pharmacotherapy Update Volume: XV No. 6 (PDF file 196 KB)
In this Issue:
Vaccine Shortage in Light of a Rise in Rabies Exposure
Connie Cheng, Pharm.D.
Formulary Update
September/October 2012
Pharmacotherapy Update Volume: XV Number 5 (PDF file 199 KB)
In this Issue:
Clobazam: A Novel Treatment for Lennox-Gastaut Syndrome
Stephanie Bass, Pharm.D.
Formulary Update
July/August 2012
Pharmacotherapy Update Volume: XV Number 4 (PDF file 213 KB)
In this Issue:
Linagliptin: An Alternative Dipeptidyl Peptidase-4 Inhibitor
Anna Powichrowski, Pharm.D.
Formulary Update, FAQ
May/June 2012
Pharmacotherapy Update Volume: XV Number 3 (PDF file 201 KB)
In this Issue:
Should N-Acetylcysteine Be Used for Contrast-Induced Nephropathy?
Amanda McDavid, Pharm.D. Candidate
Is There an Association Between Proton Pump Inhibitors and Clostridium difficile?
Natalie V. Parc, Pharm.D. Candidate
March/April 2012
Roflumilast: A New Oral, Once-Daily Therapy for COPD (PDF file 218 KB)
Mallary Wood, Pharm.D.
In this Issue: Drug Information Center, Formulary Update
January/February 2012
Brentuximab Vedotin: A Novel Therapy for Refractory Lymphomas (PDF file 178 KB)
Anthony S. Zembillas, Pharm.D.
November/December 2011
Rivaroxaban: A Novel Oral Anticoagulant (PDF file 189 KB)
Tessa Ruble, Pharm.D.
September/October 2011
A New Treatment for Acute Coronary Syndromes (PDF file 226 KB)
Horieh Pourmandi, Pharm.D.
July/August 2011
Dabigatran: An Alternative to Warfarin (PDF file 243 KB)
Cory Blacksmith, Pharm.D.
May/June 2011
Belimumab: A New Treatment for SLE (PDF file 222 KB)
Janine S. Douglas, Pharm.D.
March/April 2011
Pegloticase: A New Treatment for Gout (PDF file 169 KB)
Tessa Overman, Pharm.D. Candidate
January/February 2011
Current Therapies for Obesity (PDF file 129 KB)
Agnes Withers, Pharm.D.
November/December 2010
Pancreatic Enzyme Products Update (PDF file 173 KB)
Andrew Tong, Pharm.D.
September/October 2010
Fingolimod: A New Drug for Multiple Sclerosis (PDF file 180 KB)
Anthony Zembillas, Pharm.D. Candidate
July/August 2010
Drug Recalls (PDF file 166 KB)
Meghan Lehmann, Pharm.D., BCPS
May/June 2010
Influenza Vaccine 2010-2011 Update (PDF file 130 KB)
Marcia Wyman, Pharm.D.
January/February 2010
Denosumab: A New Therapy for Osteoporosis (PDF file 166 KB)
Candice Gehret, Pharm.D.
November/December 2009
A Review of Topical Thrombin (PDF file 123 KB)
Dragos Plesca, Pharm.D., Ph.D.
September/October 2009
Albumin Therapy in Critically Ill Patients (PDF file 120 KB)
Mihaela Popescu, Pharm.D.
July/August 2009
A New Medication for Fibromyalgia: Milnacipran
Katie Bartlett, Pharm.D.
Did You Know. . .Rufinamide (Banzel™) (page 3)
Christopher Tuttle, Pharm.D. Candidate (PDF file 168 KB)
May/June 2009
Over-the-Counter Cough and Cold Preparations
in Pediatric Patients
Krystal Fike, Pharm.D.
Did You Know. . .Opioid Shortage (page 4-5)
Amy Balata, Pharm.D. (PDF file 144 KB)
March/April 2009
Gardasil® Update: New Indications
and Postmarketing Surveillance (PDF file 149 KB)
Lisa Garrity, Pharm.D.
January/February 2009
The Use of Colony-Stimulating Factors with Myelosuppressive Chemotherapy (PDF file 705 KB)
Karissa Kusick, Pharm.D.
November/December 2008
What You Forgot About Acetaminophen (PDF file 150 KB)
Amy Schilling, Pharm.D.
September/October 2008
Guideline Update for the Diagnosis and Management of Asthma
National Asthma Education and Prevention Program
Expert Panel Report-3 (PDF file 475 KB)
Sneha Shah, Pharm.D.
July/August 2008
Influenza Season: 2008-2009 (PDF file 158 KB)
Sarah Adriance, Pharm.D.
May/June 2008
Medication Administration Through
Enteral Feeding Tubes (PDF file 112 KB)
Marcia Wyman, Pharm.D.
March/April 2008
Prevention of Infective Endocarditis: 2007 Guidelines from the American Heart Association (AHA) (PDF file 121 KB)
Sharon Sam, Pharm.D.
January/February 2008
Intravenous Immune Globulin (IVIG): A Review of Formulary Restrictions (PDF file 106 KB)
November/December 2007
Update: Erythropoiesis-Stimulating Agents, Part II (PDF file 109 KB)
Ambar Khan, Pharm.D., BCOP
September/October 2007
Update: Erythropoiesis-Stimulating Agents, Part I (PDF file 122 KB)
Amy T. Sekel, Pharm.D.
July/August 2007
NovoSeven®: Cleveland Clinic Guidelines (PDF file 145 KB)
Pam Risko, Pharm.D.
May/June 2007
Aliskiren (Tekturna®) for Hypertension (PDF file 136 KB)
Kelli Branch, Pharm.D. Candidate
March/April 2007
Ceprotin™ FDA-Approved for Treatment of Rare Clotting Disorder (PDF file 121 KB)
Abby E. Kusnerik, Pharm.D. Candidate
January/February 2007
Use of Inhaled Human Insulin in Patients with Diabetes Mellitus (PDF file 167 KB)
Linda Ghobrial, Pharm.D.
November/December 2006
Prophylaxis Against Human Papillomavirus Infections with Gardasil® Vaccine (PDF file 132 KB)
Jaime Anderson, Pharm.D.
September/October 2006
Osteonecrosis of the Jaw Associated with the
Use of Bisphosphonates: Part II (PDF file 208 KB)
Kathryn B. Nguyen, Pharm.D.
July/August 2006
Osteonecrosis of the Jaw Associated with the
Use of Bisphosphonates: Part I (PDF file 180 KB)
Kathryn B. Nguyen, Pharm.D.
May/June 2006
Medications Used
for Smoking Cessation (PDF file 317 KB)
Mandy Leonard, Pharm.D., BCPS
March/April 2006
2005 Changes to the American
Heart Association Guidelines for Cardiopulmonary Resuscitation (PDF file 148 KB)
Heather Bockheim, Pharm.D.
January/February 2006
Pharmocogenomics (PDF file 1.33 MB)
Jessica Dusky, Pharm.D. Candidate
November/December 2005
Pregabalin
(Lyrica®): Part II (PDF file 326 KB)
Chadrick Lowther, Pharm.D.
September/October 2005
Pregabalin
(Lyrica®): Part I
Chadrick Lowther, Pharm.D.
July/August 2005
Prevention
of Meningococcal Disease
Phil Chung, Pharm.D.
May/June 2005
The Cleveland
Clinic Foundation's Recommendations for Cyclooxygenase-2 Inhibitor
Use
Meghan K. Lehmann, Pharm.D.
March/April 2005
New
Therapies for the Treatment of Overactive Bladder
Abigail Bridger, Pharm.D.
January/February 2005
Emerging Therapies
in the Treatment of Type 2 Diabetes
Marc A. Earl, Pharm.D.
November/December 2004
Fosphenytoin
(Cerebyx®)
Tyrone Lin, Pharm.D.
September/October 2004
Duloxetine
(Cymbalta®)
Ian Hollis, Pharm.D Candidate
July/August 2004
Daptomycin
(Cubicin™): A New Treatment Option for Gram-Positive Infections
Amy Hirsch, Pharm.D.
May/June 2004
Namenda™
(Memantine) for Moderate-to-Severe Alzheimer's Disease
Shannon Just, Pharm.D.
Spiriva®
HandiHaler® (Tiotropium) - A New Therapy for COPD
Katie Milner, Pharm.D.
March/April 2004
New Competition
for Viagra®
Christina Collins, Pharm.D. Candidate
Seasonale®
(levonorgestrel 0.15 mg/ethinyl estradiol 0.03 mg) Extended-Cycle
Oral Contraception
Amy Decker, Pharm.D. Candidate
January/February 2004
Omalizumab:
A New Treatment for the Management of Asthma
Bridgette L. Sims, Pharm.D. Candidate
November/December 2003
Rosuvastatin:
A New Pharmacotherapy for LDL-Cholesterol Reduction
Katie E. Meister, Pharm.D.
September/October 2003
Intravenous
Pantoprazole (Protonix®)
Jeffrey Bruno, Pharm.D.
July/August 2003
New Antifungal
Agents: Additions to the Existing Armamentarium (Part 2)
Jennifer Long, Pharm.D., BCPS
May/June 2003
New Antifungal
Agents: Additions to the Existing Armamentarium (Part I)
Jennifer Long, Pharm.D., BCPS
March/April 2003
The Safety
of Ephedra and Related Alkaloids
Amy Dickson, Pharm.D. Candidate
Ezetimibe
(Zetia™)
Bernadette A. Clark, Pharm.D. Candidate
January/February 2003
Ziprasidone
Mesylate Injection
Marcia Wyman, Pharm.D.
Dietary Supplements Update: Seals-of-Approval
Enoxaparin
Clinical Pearl
Jeff Ketz, Pharm.D., BCPS
November/December 2002
5-HT3 Receptor
Antagonists and ECG Effects
Mandy C. Leonard, Pharm.D., BCPS and Michael A. Militello,
Pharm.D., BCPS
September/October 2002
Ginkgo Biloba
and Memory
Andreea Popa, Pharm.D.
July/August 2002
A Review
of Coagulation Products Used in the Treatment of Hemophilia
Nadine Chehab, Pharm.D.
March/April 2002
Bosentan (Tracleer™),
a New Agent for the Treatment of Pulmonary Arterial Hypertension
Andreea Popa, Pharm.D. Candidate
January/February 2002
Drotrecogin
alfa-Recombinant Human Activated Protein C (Xigris™)
Jeffrey P. Gonzales, Pharm.D.
September/October 2001
Type
II Heparin-Induced Thrombocytopenia: New Treatment Options
Robert Barcelona, Pharm.D.
July/August 2001
Esomeprazole
(Nexium™): A New Proton Pump Inhibitor
Mandy Leonard, Pharm.D., BCPS
May/June 2001
A
Review of Oral Antidiabetic Agents
Jeff Ketz, Pharm.D., BCPS
March/April 2001
Interactions
Between Herbs and Cardiac Medications
Mandy C. Leonard, Pharm.D., BCPS
January/February 2001
Tenecteplase
(TNKase™): A Clinical Review
Michael Militello, Pharm.D., BCPS
November/December 2000
Concerta™
for Attention-Deficit/Hyperactivity Disorder
Margaret Peters, Pharm.D.
Glucovance™,
a combination oral antihyperglycemic agent, wins FDA approval
Kristina Pascuzzi, Pharm.D. student
September/October 2000
Dofetilde: A
New Class III Antiarrhythmic
Jodie Zalewski, Pharm.D.
Submitting
Research Protocols to the Institutional Review Board
Kenneth Shermock, Pharm.D.
July/August 2000
New FDA-Approved
Indications for Risedronate
Marcia Wyman, Pharm.D. Candidate
May/June 2000
Cisapride
Withdrawal Requires Alternative Therapy
Jodie M. Zalewski, Pharm.D.
Alosetron: A New Agent for the Treatment of Irritable Bowel Syndrome
November/December 1999
The General Use
of Medications in Pregnancy
Christina H. Stack, R. Ph., Pharm.D. Candidate
Current Issues
| Archive 2021 - 2022
| Archive 2019 - 2020
| Archive 2017 - 2018
Archive 2015 - 2016
| Archive 2013 - 2014
| Complete Archive